The BIOSECURE Act would prohibit the U.S. government from contracting with, or providing grants to, U.S. companies doing ...

One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class ...

Michelle C. Werner agonized over whether the gene therapy treatment Elevidys was right for her teenage son. But to him, the ...

The overlapping symptoms of long Covid and persistent Lyme challenge patients and doctors alike. Researchers are seeking ...

The U.S. and New Zealand are the only countries that legally allow direct-to-consumer pharmaceutical advertising.

Highmark Health, an insurer that owns a chain of hospitals, will cover a handful of digital treatments for millions of its ...

Blood tests set to norms based on the physiology of white men can lead to misdiagnosis and unnecessary health scares for ...

After leading his previous company through a back-to-back IPO and M&A deal, the former chief executive of RayzeBio has raised ...

Summit’s lung cancer treatment has wowed researchers. The CEO behind it is a living challenge to the assumptions of many in ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, ...

Terns Pharmaceuticals this morning reported that its small molecule GLP-1 pill led to weight loss in a short Phase 1 study, ...

Keytruda's dominance as a mainstay in cancer immunotherapy isn’t threatened by an experimental Chinese drug, a top Merck ...